AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT04721717
- Status
- Recruiting
Conditions
- Amyotrophic Lateral Sclerosis
- Multiple Sclerosis
- Spinal Cord Injuries
- Transverse Myelitis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The UAB Institute for Arts In Medicine (AIM) is currently implementing an expressive emotional writing pilot project for adults with paralysis caused by neurological conditions such as traumatic head or spinal cord injury.
Key Dates
- Start date
- Sep 1, 2020
- Status verified
- Aug 2025
- Primary completion
- Mar 28, 2027
- Completion
- Mar 28, 2027
Study Design
- Enrollment
- 160 participants (estimated)
Arms
- Arm: People with SCIPeople with paraplegia and quadriplegia People with multiple sclerosis People with transverse myelitis Caregivers of people with amyotrophic lateral sclerosis (ALS)
Primary Outcome Measure
The Grief and Loss Scale [ Time Frame: 11 Weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| 354 School of Health Professions Building | Birmingham | Alabama | 35294 | Hon Yuen, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Birmingham, AL
By condition
By specialty
By research site
Related Studies
- Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS PatientsPHASE3 · Recruiting · AB Science · Birmingham, Alabama
- Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.PHASE1 · Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)Recruiting · Mayo Clinic · Birmingham, Alabama